Advertisement
U.S. markets closed

Stryker Corporation (SYK.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
333.00+4.00 (+1.22%)
As of 01:48PM CET. Market open.
  • Dividend

    SYK.F announced a cash dividend of 0.80 with an ex-date of Mar. 27, 2024

Stryker Corporation

1941 Stryker Way
Portage, MI 49002
United States
269 385 2600
https://www.stryker.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees52,000

Key Executives

NameTitlePayExercisedYear Born
Dylan B. CrottyPresident of InstrumentsN/AN/AN/A
Maurice Ben-MayorPresident of South PacificN/AN/AN/A
Stuart A. J. SilkPresident of Europe, Middle East, Africa, Latin America & CanadaN/AN/AN/A
Mr. Brian J. WhitePresident of Sustainability SolutionsN/AN/AN/A
Bradford L. SaarPresident of MedicalN/AN/AN/A
Brent W. LaddPresident of EndoscopyN/AN/AN/A
Mr. Preston WellsVP & Group CFO of Orthopaedics and SpineN/AN/AN/A
Mr. Mike PanosNorth American President of Trauma & Extremities and Global R&DN/AN/AN/A
Donald E. PayerlePresident of Joint ReplacementN/AN/AN/A
Dragana BunjevacPresident of Eastern Europe, Middle East & AfricaN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Corporate Governance

Stryker Corporation’s ISS Governance QualityScore as of March 1, 2024 is 6. The pillar scores are Audit: 7; Board: 5; Shareholder Rights: 6; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.